Suchergebnisse - "Nishimura, Mitsuhiro"

PubPharm (82)

1

Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy

enthalten in: bioRxiv.org | 2024

von Ren, Z. | Nishimura, M. | Tjan, L. | +15

2

Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein

enthalten in: Journal of virology | 2024

von Ishimaru, H. | Nishimura, M. | Shigematsu, H. | +5

3

Human herpesvirus 6A nuclear matrix protein U37 interacts with heat shock transcription factor 1 and activates the heat shock response

enthalten in: Journal of virology | 2023

von Huang, J. | Arii, J. | Hirai, M. | +2

4

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population

enthalten in: Journal of infection and public health | 2023

von Sutandhio, S. | Furukawa, K. | Kurahashi, Y. | +7

5

Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants

enthalten in: Journal of virology | 2023

von Ishimaru, H. | Nishimura, M. | Tjan, L. | +18

6

IgG4-Related Pericarditis Diagnosed by Accumulated Pericardial Effusion

enthalten in: Case reports in cardiology | 2023

von Sugawara, H. | Takahashi, T. | Kimura, Y. | +4

7

Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021

enthalten in: bioRxiv.org | 2023

von Ren, Z. | Furukawa, K. | Nishimura, M. | +15

8

The Number of Coronavirus Disease 2019 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

enthalten in: The Journal of infectious diseases | 2022

von Furukawa, K. | Kurahashi, Y. | Ishimaru, H. | +8

9

The Trend of Neutralizing Antibody Response Against SARS-CoV-2 and the Cytokine/Chemokine Release in Patients with Differing Severities of COVID-19: All Individuals Infected with SARS-CoV-2 Obtained Neutralizing Antibody

enthalten in: bioRxiv.org | 2022

von Tjan, L. | Nagano, T. | Furukawa, K. | +6

10

Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination

enthalten in: The Journal of infectious diseases | 2022

von Tjan, L. | Furukawa, K. | Kurahashi, Y. | +4

CommentOn: J Infect Dis. 2022 Oct 17;226(8):1372-1381. - PMID 35267040

1
2
3
4
5
6
7
8
9
Nächster »
[9]